相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reactive Oxygen Species (ROS): Key Components in Cancer Therapies
Biswa Mohan Sahoo et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2022)
A modular ROS-responsive platform co-delivered by 10-hydroxycampto-thecin and dexamethasone for cancer treatment
Qingye Meng et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis
Xueying Ren et al.
REDOX BIOLOGY (2021)
Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram
Ting Sun et al.
CELL COMMUNICATION AND SIGNALING (2020)
Nanoscale Copper(II)-Diethyldithiocarbamate Coordination Polymer as a Drug Self-Delivery System for Highly Robust and Specific Cancer Therapy
Ying Peng et al.
MOLECULAR PHARMACEUTICS (2020)
Drug Repurposing in Human Cancers
Gabriele Grassi et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer
Imran Shair Mohammad et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma
Jiayi Huang et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents
Elmira Ekinci et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2019)
Highly Stable, Coordinated Polymeric Nanoparticles Loading Copper(II) Diethyldithiocarbamate for Combinational Chemo/Chemodynamic Therapy of Cancer
Xinyu Peng et al.
BIOMACROMOLECULES (2019)
A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy
Yifan Wang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Development and Characterization of the Solvent-Assisted Active Loading Technology (SALT) for Liposomal Loading of Poorly Water-Soluble Compounds
Griffin Pauli et al.
PHARMACEUTICS (2019)
Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways
Yi Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Disulfiram/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes
Saeed Hassani et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers
Wu Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Zdenek Skrott et al.
NATURE (2017)
Disulfiram is a slow-binding partial noncompetitive inhibitor of 20S proteasome activity
Brian B. Hasinoff et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
Clinical features and outcome in patients with osseomuscular type of Wilson's disease
Hao Yu et al.
BMC NEUROLOGY (2017)
A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
Hovav Nechushtan et al.
ONCOLOGIST (2015)
Liposomes in tissue engineering and regenerative medicine
Nelson Monteiro et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2014)
Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-κB pathway inhibition
Jie Zha et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners
Tetsuhiro Chiba et al.
PLOS ONE (2014)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Liposome: classification, preparation, and applications
Abolfazl Akbarzadeh et al.
NANOSCALE RESEARCH LETTERS (2013)
Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells
Zdenek Skrott et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate Complexes Show Various Activities Against the Proteasome in Breast Cancer Cells
Boris Cvek et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
Di Chen et al.
CANCER RESEARCH (2006)
Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbilne with promising antitumor activity
SC Semple et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Disulfiram is a potent modulator of multidrug transporter Cdr1p of Candida albicans
S Shukla et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Characterization of cholesterol-sphingomyelin domains and their dynamics in bilayer membranes
AV Samsonov et al.
BIOPHYSICAL JOURNAL (2001)
分享论文
